Relmada Therapeutics
Selena Chen, CPA, currently serves as the Accounting Manager at Relmada Therapeutics, Inc. since April 2023, following a position as Manager at CFGI from February 2022 to April 2023. Previous professional experience includes roles at Marcum LLP from July 2017 to January 2022, where Selena progressed from Senior Auditor to Audit Manager, along with auditor positions at GBH CPAs, PC and Canady & Canady P.C. Earlier in the career, a Financial Analyst Intern role at Intelligent Epitaxy Technology, Inc., and experience as an Audit Associate at PwC contributed to a strong foundation in accounting and finance. Educational qualifications include a Master of Science in Finance from The University of Texas at Dallas and a Bachelor's degree in Accounting from National Taiwan University.
This person is not in any offices
Relmada Therapeutics
2 followers
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain.